Non-pegylated Liposomal Doxorubicin (Myocet ®) Plus Docetaxel (Taxotere ®) (MYTAX), as First-line Chemotherapy (CHT), in Metastatic Breast Cancer (MBC): Results of a Phase II Study

被引：0
|
作者：
Imperatori, L. [1 ]
Lippe, P. [1 ]
Trapuzzano, C. [1 ]
Laici, G. [1 ]
Cappelletti, C. [1 ]
Tamburrano, T. [1 ]
Mattioli, R. [1 ]
机构：
[1] Osped Santa Croce, Fano, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)71517-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S353 / S353
页数：1
相关论文
共 50 条
  • [41] A randomized phase II study of alternating and sequential regimens of docetaxel and doxorubicin as first-line chemotherapy for metastatic breast cancer
    Paridaens, R
    Van Aelst, F
    Georgoulias, V
    Samonnig, H
    Cocquyt, V
    Zielinski, C
    Hausmaninger, H
    Willemse, P
    Boudraa, Y
    Wildiers, J
    Ramazeilles, C
    Azli, N
    ANNALS OF ONCOLOGY, 2003, 14 (03) : 433 - 440
  • [42] Phase II study of sequential administration of docetaxel followed by doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer
    Khayat, D
    Chollet, P
    Antoine, EC
    Monfardini, S
    Ambrosini, G
    Benhammouda, A
    Mazen, MF
    Sorio, R
    Borg-Olivier, O
    Ramazeilles, C
    Azli, N
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (14) : 3367 - 3375
  • [43] WALT trial (Phase I-II): Weekly non-pegylated liposomal anthracycline and taxane combination in first-line breast cancer chemotherapy
    Rosati, M. S.
    Raimondi, C.
    Quadrini, S.
    De Sanctis, R.
    Stumbo, L.
    Gori, B.
    Del Signore, E.
    Poleggi, M. P.
    Di Seri, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [44] Pegylated liposomal doxorubicin plus carboplatin in patients with metastatic breast cancer: a phase II study
    Collea, R. P.
    Kruter, F. W.
    Cantrell, J. E.
    George, T. K.
    Kruger, S.
    Favret, A. M.
    Lindquist, D. L.
    Melnyk, A. M.
    Pluenneke, R. E.
    Shao, S. H.
    Crockett, M. W.
    Asmar, L.
    O'Shaughnessy, J.
    ANNALS OF ONCOLOGY, 2012, 23 (10) : 2599 - 2605
  • [45] A phase II study of docetaxel (T) and capecitabine W combination chemotherapy as first-line chemotherapy for patients (pts) with metastatic breast cancer (MBC).
    Lim, HS
    Lee, HG
    Chun, JH
    Lee, JJ
    Lee, JS
    Ro, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 100S - 100S
  • [46] Interim safety analysis of a randomized phase III study evaluating pegylated liposomal doxorubicin (PLD) versus capecitabine as first-line chemotherapy for metastatic breast cancer (MBC): The PELICAN study
    Harbeck, N.
    Saupe, S.
    Kerber, A.
    Lueck, H. J.
    Jackisch, C.
    Untch, M.
    Schmidt, M.
    Jaeger, E.
    Al-Batran, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [47] Multicenter Phase II Study of Pegylated Liposomal Doxorubicin in Combination with Vinorelbine as First-Line Treatment in Elderly Patients with Metastatic Breast Cancer
    Mlineritsch, Brigitte
    Schabel-Moser, Renate
    Andel, Johannes
    Fridrik, Michael
    Moik, Martin
    Mayer, Peter
    Russ, Gudrun
    Rass, Christof
    Greil, Richard
    ONKOLOGIE, 2009, 32 (1-2): : 18 - 24
  • [48] Trastuzumab plus capecitabine and docetaxel as first-line therapy for metastatic breast cancer: Phase II results
    Gennatas, C. G.
    Michalaki, V.
    Gennatas, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [49] A multicenter randomized phase II study of nonpegylated liposomal doxorubicin plus vinorelbine versus nonpegylated liposomal doxorubicin plus cyclophosphamide as first line in locally advanced breast cancer (LABC) or metastatic breast cancer (MBC): Safety results
    Lorusso, V.
    Leo, S.
    Ciccarese, M.
    Giotta, F.
    Bordonaro, R.
    Filippelli, G.
    Del Prete, S.
    Piano, A.
    Gebbia, V.
    Pisconti, S.
    Colucci, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] A Phase II Randomized Crossover Study of Liposomal Doxorubicin Versus Weekly Docetaxel in the First-line Treatment of Women With Metastatic Breast Cancer
    Yardley, Denise A.
    Burris, Howard A., III
    Spigel, David R.
    Clark, Bobby L.
    Vazquez, Elizabeth
    Shipley, Dianna
    Barton, John
    Thompson, Dana
    Montes, Ignacio
    Greco, F. Anthony
    Hainsworth, John D.
    CLINICAL BREAST CANCER, 2009, 9 (04) : 247 - 252
12345